Ironwood taps Protagonist for novel peptide therapeutics
This article was originally published in Scrip
Executive Summary
Ironwood Pharmaceuticals is looking to build on peptide expertise of Australian origin in an alliance with Protagonist Therapeutics for the discovery of novel therapeutics across various areas of unmet medical need.